Antinuclear antibody induced by procainamide. A prospective study.
D000328:Adult; D000368:Aged; D000974:Antibodies, Antinuclear / Q000032:analysis; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D001323:Autoantibodies / Q000032:analysis*; D003165:Complement System Proteins / Q000032:analysis; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007841:Latex Fixation Tests; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D011342:Procainamide / Q000008:administration & dosage / Q000009:adverse effects*; D011446:Prospective Studies; D012217:Rheumatoid Factor / Q000032:analysis; D013997:Time Factors; D005719:gamma-Globulins / Q000032:analysis
D000974:Antibodies, Antinuclear; D001323:Autoantibodies; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D005719:gamma-Globulins; D003165:Complement System Proteins; D012217:Rheumatoid Factor; D011342:Procainamide